A new documentary revisits the life and career of Lamar Odom, examining the circumstances that led to his near-fatal overdose in 2015 and the personal and professional consequences that followed.

The film, part of Untold, presents a detailed account of Odom’s trajectory from a prominent National Basketball Association player to a figure defined by struggles with addiction and loss.

Directed by Ryan Duffy, the documentary situates Odom’s life within a broader narrative shaped by early exposure to trauma. Duffy said Odom’s experiences can be understood as a prolonged response to repeated encounters with loss, beginning in childhood.

Odom’s mother died of colon cancer when he was 10, and his father struggled with heroin addiction, remaining largely absent from his upbringing.Odom rose to prominence as a versatile forward, achieving success with the Los Angeles Lakers, where he won two NBA championships alongside Kobe Bryant.

His playing style, characterised by positional flexibility, has been widely noted in basketball analysis as anticipating the modern emphasis on multi-role athletes. Despite these achievements, the documentary underscores how his career was repeatedly overshadowed by personal challenges.

The central event examined in the film is Odom’s medical emergency in October 2015, when he was found unconscious at the Love Ranch. Reports at the time indicated he had been on a prolonged drug binge.

According to the documentary, Odom suffered kidney failure, multiple heart attacks and a series of strokes. He was placed in a medically induced coma, with doctors initially expressing concern about the likelihood of survival without lasting neurological damage.

The incident drew widespread media attention, becoming one of the most high-profile sports-related crises of the period. Data from Google Trends showed Odom as the most searched living individual that year, reflecting the scale of public interest.

Coverage in tabloid media framed the episode as the culmination of ongoing substance abuse issues, which had previously resulted in legal difficulties, including a 2013 driving under the influence conviction.At the time of the incident, Odom’s personal life was also under scrutiny due to his relationship with Khloé Kardashian.

The documentary provides new details about their marriage, which began shortly after they met at an event connected to Ron Artest in 2009. Kardashian describes the rapid progression of their relationship, including their marriage within a month and Odom’s involvement in her family’s expanding reality television presence.

Kardashian’s account also addresses the impact of Odom’s substance use and infidelity on their relationship. She said she took active steps to manage the public narrative around his behaviour, including intervening in situations that might have attracted media attention.

Following an unsuccessful intervention in 2013, she filed for divorce, though the process was not finalised at the time of Odom’s hospitalization.According to the documentary, this legal status enabled Kardashian to act as Odom’s next of kin during his medical crisis, influencing decisions regarding his treatment.

She claims she played a role in ensuring life-sustaining measures were maintained during a critical period. The film also includes her reflection that her actions may have inadvertently enabled Odom’s addiction.Odom does not dispute these accounts in the documentary.

Instead, he acknowledges the impact of his behaviour on those around him, including his children. His daughter, Destiny, describes a pattern in which Odom avoided prolonged reflection on personal setbacks, focusing instead on moving forward.

The film suggests this approach may have functioned as a coping mechanism shaped by earlier experiences of loss, including the death of his infant son in 2006.The documentary also features commentary from Phil Jackson, who coached Odom during his tenure with the Lakers.

Jackson describes Odom as a team-oriented player who contributed to a collective dynamic, while also noting the challenges posed by his off-court life. Jackson’s perspective adds a professional dimension to the narrative, situating Odom’s personal struggles within the context of team performance and league expectations.

Duffy said Kardashian’s participation in the project significantly influenced its structure. Initially planned as a secondary element, her interview expanded in scope following an extended on-camera discussion, leading to substantial revisions in the film’s editing process.

Her account provides additional context to events that had previously been reported primarily through media coverage.The documentary also addresses Odom’s post-recovery trajectory. Following his discharge from hospital, he resumed public appearances, including attendance at Bryant’s final NBA game.

However, the film indicates that his recovery process did not include sustained engagement with therapy, a decision that family members suggest may have affected his long-term stability.In recent developments referenced in the documentary, Odom entered a 30-day rehabilitation program for marijuana use and faces ongoing legal proceedings related to a driving offence.

These events are presented as part of a continuing pattern rather than a resolved narrative, with Odom describing himself as still seeking direction following his survival.Duffy said Odom’s willingness to present his experiences without attempting to impose a structured resolution distinguishes the documentary from other athlete-focused productions.

He noted that many subjects seek to frame their narratives around recovery and closure, whereas Odom’s account remains open-ended, reflecting ongoing uncertainty.The film situates Odom’s story within a broader context of sports biographies that examine the intersection of fame, personal adversity and public perception.

By focusing on both his achievements and his struggles, it provides a comprehensive account of a career shaped by both success and instability, without presenting a definitive resolution.

The global drug crisis is expanding in both scale and complexity, with new data pointing to a steady rise in consumption, production, and associated harms across regions. According to the United Nations Office on Drugs and Crime (UNODC), an estimated 292 million people used drugs in 2022, marking a 20% increase over the past decade.

This upward trend reflects not only population growth but also deeper structural challenges tied to inequality, conflict, and evolving illicit markets.Down To EarthCannabis remains the most widely used substance globally, with 228 million users, followed by opioids at 60 million, amphetamines at 30 million, cocaine at 23 million, and ecstasy at 20 million.

While these figures highlight the breadth of usage, the more pressing concern lies in the growing number of individuals developing drug use disorders. UNODC estimates that around 64 million people worldwide suffer from such conditions, yet access to treatment remains limited and uneven.

Despite the scale of the problem, treatment coverage remains critically low. Only one in 11 people with drug use disorders receives any form of medical or psychological support, according to UN data.

The gap is even more pronounced among women, with only one in 18 receiving treatment compared to one in seven men. These disparities point to systemic barriers, including stigma, lack of healthcare infrastructure, and gender-based inequalities in access to services.

Down To EarthPolitical EconomistHealth risks associated with drug use are also intensifying, particularly with the emergence of new synthetic substances. Nitazenes, a class of synthetic opioids more potent than fentanyl, have been linked to rising overdose deaths in several high-income countries.

At the same time, harm reduction strategies such as supervised consumption sites and naloxone distribution programmes have been introduced in some countries, though their availability remains inconsistent globally.

The supply side of the drug economy is also undergoing significant transformation. The global cocaine market, in particular, has seen rapid expansion, with production, seizures, and consumption all reaching record levels in recent years.

Global cocaine production exceeded 3,700 tonnes in 2023, driven largely by increased cultivation in Latin America and improved yields. Synthetic drugs are emerging as another dominant force, reshaping trafficking patterns due to their low production costs and ease of distribution.

Amphetamine-type stimulants now account for a substantial share of global synthetic drug seizures, while new psychoactive substances continue to proliferate.

In 2024 alone, a record 688 unique new psychoactive substances were reported worldwide, highlighting the rapid pace of innovation within illicit markets. UNODCThese developments are closely linked to organised crime networks, which have diversified their operations across regions.

Drug trafficking routes are increasingly integrated with other forms of illicit activity, including financial fraud and illegal resource extraction. In parts of Southeast Asia, for example, industrial-scale methamphetamine production has surged, supported by transnational networks and ongoing political instability.

Underlying the expansion of drug markets are broader socio-economic factors. Poverty, unemployment, and displacement continue to push vulnerable populations toward both drug use and participation in illicit economies. In some regions, farmers have turned to cultivating narcotic crops such as opium as a means of survival, particularly in areas affected by conflict or economic disruption.

The human cost extends beyond individual users to families and communities. Drug-related crime remains significant, with an estimated 7 million people globally coming into contact with law enforcement for drug-related offences in 2022.

Of these, a large proportion were linked to possession or personal use, raising questions about the balance between criminal justice approaches and public health strategies.

At the same time, younger populations are increasingly affected. Data from multiple regions indicate a rise in early drug exposure, with youth representing a growing share of new users. This trend has implications for long-term health outcomes, workforce participation, and social stability.

Governments have adopted a mix of enforcement, prevention, and treatment strategies to address the crisis, but results remain uneven. While some countries have expanded harm reduction programmes and public health interventions, others continue to rely heavily on punitive approaches.

Experts argue that without coordinated international action, disparities in policy responses will continue to undermine progress.The evolving nature of drug markets particularly the rise of synthetic substances and digital trafficking networks poses additional challenges for regulation and enforcement.

As supply chains become more decentralised and adaptable, traditional control mechanisms are increasingly strained.

,The data suggests that the global drug problem is no longer confined to specific regions or substances but has become a widespread and multifaceted issue, shaped by economic, social, and technological forces.